Avasara Finance Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 10, 2025, 11:18 pm

Competitors of Avasara Finance Ltd

All Competitor Stocks of Avasara Finance Ltd

Quarterly Result

Last Updated: August 1, 2025, 6:55 am

Below is a detailed analysis of the quarterly data for Avasara Finance Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Expenses, as of Jun 2025, the value is 0.19 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.08 Cr. (Mar 2025) to 0.19 Cr., marking an increase of 0.11 Cr..
• For Operating Profit, as of Jun 2025, the value is -0.19 Cr.. The value appears to be declining and may need further review. It has decreased from -0.08 Cr. (Mar 2025) to -0.19 Cr., marking a decrease of 0.11 Cr..
• For OPM %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
• For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Profit before tax, as of Jun 2025, the value is -0.19 Cr.. The value appears to be declining and may need further review. It has decreased from -0.08 Cr. (Mar 2025) to -0.19 Cr., marking a decrease of 0.11 Cr..
• For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
• For Net Profit, as of Jun 2025, the value is -0.19 Cr.. The value appears to be declining and may need further review. It has decreased from -0.08 Cr. (Mar 2025) to -0.19 Cr., marking a decrease of 0.11 Cr..
• For EPS in Rs, as of Jun 2025, the value is -0.38. The value appears to be declining and may need further review. It has decreased from -0.16 (Mar 2025) to -0.38, marking a decrease of 0.22.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 3:51 am

Growth

Last Updated: September 5, 2025, 2:31 pm

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Avasara Finance Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -0.89. This value is below the healthy minimum of 5. It has decreased from 0.43 (Mar 24) to -0.89, marking a decrease of 1.32.
• For Diluted EPS (Rs.), as of Mar 25, the value is -0.89. This value is below the healthy minimum of 5. It has decreased from 0.43 (Mar 24) to -0.89, marking a decrease of 1.32.
• For Cash EPS (Rs.), as of Mar 25, the value is -0.89. This value is below the healthy minimum of 3. It has decreased from 0.43 (Mar 24) to -0.89, marking a decrease of 1.32.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 4.02. It has decreased from 4.91 (Mar 24) to 4.02, marking a decrease of 0.89.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 4.02. It has decreased from 4.91 (Mar 24) to 4.02, marking a decrease of 0.89.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.00. It has decreased from 2.66 (Mar 24) to 0.00, marking a decrease of 2.66.
• For PBDIT / Share (Rs.), as of Mar 25, the value is -0.89. This value is below the healthy minimum of 2. It has decreased from 0.43 (Mar 24) to -0.89, marking a decrease of 1.32.
• For PBIT / Share (Rs.), as of Mar 25, the value is -0.89. This value is below the healthy minimum of 0. It has decreased from 0.43 (Mar 24) to -0.89, marking a decrease of 1.32.
• For PBT / Share (Rs.), as of Mar 25, the value is -0.89. This value is below the healthy minimum of 0. It has decreased from 0.43 (Mar 24) to -0.89, marking a decrease of 1.32.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -0.89. This value is below the healthy minimum of 2. It has decreased from 0.43 (Mar 24) to -0.89, marking a decrease of 1.32.
• For PBDIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has decreased from 16.34 (Mar 24) to 0.00, marking a decrease of 16.34.
• For PBIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has decreased from 16.30 (Mar 24) to 0.00, marking a decrease of 16.30.
• For PBT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has decreased from 16.30 (Mar 24) to 0.00, marking a decrease of 16.30.
• For Net Profit Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 16.30 (Mar 24) to 0.00, marking a decrease of 16.30.
• For Return on Networth / Equity (%), as of Mar 25, the value is -22.20. This value is below the healthy minimum of 15. It has decreased from 8.82 (Mar 24) to -22.20, marking a decrease of 31.02.
• For Return on Capital Employeed (%), as of Mar 25, the value is -20.62. This value is below the healthy minimum of 10. It has decreased from 7.99 (Mar 24) to -20.62, marking a decrease of 28.61.
• For Return On Assets (%), as of Mar 25, the value is -17.97. This value is below the healthy minimum of 5. It has decreased from 7.08 (Mar 24) to -17.97, marking a decrease of 25.05.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. It has decreased from 0.48 (Mar 24) to 0.00, marking a decrease of 0.48.
• For Current Ratio (X), as of Mar 25, the value is 7.53. This value exceeds the healthy maximum of 3. It has decreased from 8.68 (Mar 24) to 7.53, marking a decrease of 1.15.
• For Quick Ratio (X), as of Mar 25, the value is 7.53. This value exceeds the healthy maximum of 2. It has decreased from 8.68 (Mar 24) to 7.53, marking a decrease of 1.15.
• For Enterprise Value (Cr.), as of Mar 25, the value is 16.14. It has increased from 13.44 (Mar 24) to 16.14, marking an increase of 2.70.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 10.10 (Mar 24) to 0.00, marking a decrease of 10.10.
• For EV / EBITDA (X), as of Mar 25, the value is -36.22. This value is below the healthy minimum of 5. It has decreased from 61.81 (Mar 24) to -36.22, marking a decrease of 98.03.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 10.12 (Mar 24) to 0.00, marking a decrease of 10.12.
• For Price / BV (X), as of Mar 25, the value is 8.04. This value exceeds the healthy maximum of 3. It has increased from 5.48 (Mar 24) to 8.04, marking an increase of 2.56.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 10.12 (Mar 24) to 0.00, marking a decrease of 10.12.
• For EarningsYield, as of Mar 25, the value is -0.02. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to -0.02, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness